Plavix and Zioptan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Plavix (clopidogrel bisulfate) and Zioptan (tafluprost). Common drug interactions include cough among females and eye irritation among males.

The phase IV clinical study analyzes what interactions people have when they take Plavix and Zioptan. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Plavix?

Plavix has active ingredients of clopidogrel bisulfate. It is often used in stent. eHealthMe is studying from 151,178 Plavix users. Check the latest studies of Plavix.

What is Zioptan?

Zioptan has active ingredients of tafluprost. It is often used in glaucoma. eHealthMe is studying from 2,512 Zioptan users. Check the latest studies of Zioptan.



On Jul, 26, 2026

22 people who take Plavix and Zioptan together, and have interactions are studied.

Plavix and Zioptan drug interactions.

What are the common drug interactions of Plavix and Zioptan, by gender? *:

female:

  1. Cough
  2. Dry eye (lack of adequate tears)
  3. Erythema of eyelid (redness of the eyelid)
  4. Eye pruritus (eye itching)
  5. Hypersensitivity
  6. Lip swelling
  7. Ocular hyperaemia (an abnormally large amount of blood in eye)
  8. Pruritus (severe itching of the skin)
  9. Anterior chamber inflammation
  10. Corneal endotheliitis (an immune response within the endothelium in blood vessels)

male:

  1. Eye irritation
  2. Balance disorder
  3. Unresponsive to stimuli
  4. Dizziness
  5. Fall
  6. Drug ineffective
  7. Death
  8. Eye haemorrhage (bleeding in the eye)
  9. Intraocular pressure increased
  10. Lethargy (tiredness)

What are the common drug interactions of Plavix and Zioptan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Eye irritation
  2. Cough
  3. Dizziness
  4. Drug ineffective
  5. Eye haemorrhage (bleeding in the eye)
  6. Fall
  7. Headache (pain in head)
  8. Intraocular pressure increased
  9. Ulcerative keratitis (ulcerative inflammation of the cornea)
  10. Vision blurred

What are the existing conditions these people have? *

  1. Prostate Cancer: 5 people, 22.73%
  2. Neurotrophic Keratopathy (decreased corneal sensitivity and poor corneal healing): 3 people, 13.64%
  3. Hypoaesthesia Eye (reduced sense of touch or sensation on eyes): 3 people, 13.64%

* Approximation only. Some reports may have incomplete information.

Do you take Plavix and Zioptan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Plavix and Zioptan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Plavix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zioptan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Plavix and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zioptan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on clopidogrel bisulfate and tafluprost (the active ingredients of Plavix and Zioptan, respectively), and Plavix and Zioptan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: